| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039278093 |
| P356 | DOI | 10.1007/S11892-014-0567-0 |
| P698 | PubMed publication ID | 25398206 |
| P5875 | ResearchGate publication ID | 268336496 |
| P50 | author | Helen Barrett | Q42883371 |
| P2093 | author name string | Leonie K Callaway | |
| Marloes Dekker Nitert | |||
| Luisa F Gomez Arango | |||
| P2860 | cites work | A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy | Q21090918 |
| Probiotics for prevention of necrotizing enterocolitis in preterm infants | Q24197461 | ||
| Probiotics for prevention of necrotizing enterocolitis in preterm infants | Q24235681 | ||
| Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis | Q84068152 | ||
| [Is diabetes mellitus worth treating?] | Q87785792 | ||
| Probiotics in infants for prevention of allergic disease and food hypersensitivity | Q24243561 | ||
| Probiotics for preventing preterm labour | Q24246388 | ||
| Enterotypes of the human gut microbiome | Q24489818 | ||
| Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups | Q24544895 | ||
| A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
| Structure, function and diversity of the healthy human microbiome | Q24626370 | ||
| Intestinal microbiota in human health and disease: the impact of probiotics | Q24628739 | ||
| Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
| Probiotic use in clinical practice: what are the risks? | Q28245049 | ||
| Probiotics, prebiotics, and synbiotics | Q28279222 | ||
| Maternal obesity and risk of gestational diabetes mellitus | Q28297113 | ||
| A metagenome-wide association study of gut microbiota in type 2 diabetes | Q29547726 | ||
| The human microbiome: at the interface of health and disease | Q29614801 | ||
| Epidemiology and causes of preterm birth | Q29615799 | ||
| Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults | Q29617576 | ||
| The association of maternal adult weight trajectory with preeclampsia and gestational diabetes mellitus | Q33754065 | ||
| High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model | Q33835890 | ||
| Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings | Q33998828 | ||
| Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? | Q34153569 | ||
| Toward effective probiotics for autism and other neurodevelopmental disorders | Q34199920 | ||
| Bacterial vaginosis, Atopobium vaginae and nifuratel | Q34232496 | ||
| IBD-what role do Proteobacteria play? | Q34255700 | ||
| Microbiota and diabetes: an evolving relationship. | Q34420231 | ||
| Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion. | Q34451283 | ||
| Are probiotics safe for use during pregnancy and lactation? | Q34627593 | ||
| The vaginal microbiome: new information about genital tract flora using molecular based techniques | Q34663224 | ||
| Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? | Q34899441 | ||
| Major faecal microbiota shifts in composition and diversity with age in a geographically restricted cohort of mothers and their children. | Q35013345 | ||
| Stability of the maternal gut microbiota during late pregnancy and early lactation | Q35047861 | ||
| Maternal insulin resistance and preeclampsia | Q35079625 | ||
| Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? | Q35132145 | ||
| Gut microbiota-generated metabolites in animal health and disease | Q35170535 | ||
| The placenta harbors a unique microbiome | Q35171983 | ||
| Intake of probiotic food and risk of preeclampsia in primiparous women: the Norwegian Mother and Child Cohort Study | Q35465853 | ||
| The potential role of probiotics in the management of childhood autism spectrum disorders. | Q35494817 | ||
| Childhood obesity: a global public health crisis | Q35755066 | ||
| Host remodeling of the gut microbiome and metabolic changes during pregnancy | Q36421887 | ||
| SPRING: an RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women | Q36648799 | ||
| Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms | Q36857761 | ||
| Diversity of the gut microbiota and eczema in early life | Q36924911 | ||
| Maternal obesity: pregnancy complications, gestational weight gain and nutrition | Q37067632 | ||
| Obesity and the gut microbiome: Striving for causality. | Q37133415 | ||
| Diversified microbiota of meconium is affected by maternal diabetes status | Q37284798 | ||
| Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases | Q37551730 | ||
| The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women | Q37564500 | ||
| Probiotics and prebiotics in pediatrics | Q37813322 | ||
| Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood--a meta-analysis | Q37905185 | ||
| Can nutritional modulation of maternal intestinal microbiota influence the development of the infant gastrointestinal tract? | Q38044621 | ||
| Potential of immunoglobulin A to prevent allergic asthma | Q38108303 | ||
| The role of lifestyle interventions in the prevention of gestational diabetes | Q38169566 | ||
| Practical approaches to probiotics use. | Q42216604 | ||
| Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women | Q43141586 | ||
| Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women | Q43481704 | ||
| Maternal dietary counseling reduces total and LDL cholesterol postpartum | Q43735053 | ||
| The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years | Q43795850 | ||
| Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants | Q43933885 | ||
| Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? | Q44138178 | ||
| Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates | Q46446325 | ||
| Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial | Q47407913 | ||
| Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. | Q47414505 | ||
| Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years | Q48543528 | ||
| Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. | Q50627720 | ||
| Pre- and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. | Q50797045 | ||
| Effect of daily consumption of probiotic yoghurt on lipid profiles in pregnant women: a randomized controlled clinical trial. | Q51365124 | ||
| Probiotic Lactobacillus rhamnosus GR-1 supernatant prevents lipopolysaccharide-induced preterm birth and reduces inflammation in pregnant CD-1 mice. | Q54224918 | ||
| Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up. | Q54577430 | ||
| Gestational Diabetes Mellitus | Q56428291 | ||
| Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: A randomized placebo-controlled trial | Q61988217 | ||
| Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study | Q61988229 | ||
| Probiotics for pregnant women and preterm neonates | Q82695944 | ||
| P433 | issue | 1 | |
| P921 | main subject | probiotics | Q1816730 |
| P304 | page(s) | 567 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Current diabetes report | Q26841965 |
| P1476 | title | Probiotics and pregnancy. | |
| P478 | volume | 15 |
| Q55399333 | Effect of maternal supplement beverage with and without probiotics during pregnancy and lactation on maternal and infant health: a randomized controlled trial in the Philippines. |
| Q37261491 | Is there a value for probiotic supplements in gestational diabetes mellitus? A randomized clinical trial |
| Q90478478 | Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants |
| Q39442525 | Prenatal and postnatal administration of prebiotics and probiotics |
Search more.